What is GHK-Cu?
GHK-Cu is a small copper-binding peptide found naturally in your blood — abundant in youth, declining with age — studied for skin renewal, collagen signaling, and tissue repair.
These articles cover how it's thought to work, what the cosmetic and preclinical research shows, and how it fits into blends like KLOW. Injectable GHK-Cu is compounded and prescription-only: a licensed provider reviews every request. It's also part of the KLOW blend, so if you're comparing the single peptide with the blend, the articles below cover both.
9 articles on this topic
-
KLOW Peptide Side Effects: What the Evidence Shows
KLOW peptide side effects do not yet have reliable rates or a complete clinical list. The blend combines four peptides, so its clearest known risks are injection-site reactions, immune reactions, compounding-related problems, and effects that human studies have not measured.
-
KLOW Peptide Benefits: What Each Component Adds
KLOW brings four peptide research rationales into one compounded formulation. The evidence runs from cell studies to animal models, but no clinical trial has tested the finished blend.
-
GHK-Cu Dosage: How Prescribers Set the Amount
There is no validated human injection dose for GHK-Cu. Topical studies disclose several concentrations, while compounded injection amounts come from clinical practice and must be tied to the exact vial and the person being treated.
-
KLOW vs GLOW: What KPV Adds to the Blend
KLOW and GLOW share BPC-157, TB-500, and GHK-Cu; KLOW adds KPV, an inflammation-focused tripeptide backed by cell and mouse studies—not blend-level human trials.
-
GHK-Cu Side Effects: Topical vs Injectable
GHK-Cu side effects are usually mild with topical cosmetics, but injectable GHK-Cu has no long-term human safety data. Route is the difference that matters.
-
KLOW Peptide Dosage: Why the Blend Is Dosed as One
There is no universal dose for KLOW. Its four peptides come in one fixed-ratio vial, so a prescriber adjusts the finished blend rather than setting four separate component doses.
-
Inside the Glow Peptide Blend
Glow combines three peptides with non-overlapping jobs — BPC-157 signals new blood-vessel growth, TB-500 binds the cell-scaffolding protein actin, and GHK-Cu delivers copper to the enzyme that cross-links collagen.
-
KLOW Peptide Blend: Four Peptides, One Vial
KLOW combines four peptides — BPC-157, TB-500, GHK-Cu, and KPV — in one compounded vial, each mapped to a different phase of tissue repair.
-
GHK-Cu Benefits: The Copper Peptide, Explained
GHK-Cu benefits start from one well-documented fact: blood levels of this three-amino-acid copper peptide fall from roughly 200 ng/mL at age 20 to about 80 ng/mL by age 60.